Hedge funds cut NFLX, keep big bets on MSFT, AMZN, add NVDA
Cryoport, Inc. (NASDAQ:CYRX), a $319 million market cap company, saw its President and CEO Jerrell Shelton sell a total of 339,720 shares of common stock between June 17 and June 20, 2025. The sales, executed under a pre-arranged trading plan, resulted in proceeds of $2,289,781. The shares were sold at weighted average prices ranging from $6.4732 to $6.812. According to InvestingPro data, the stock has shown significant volatility with a beta of 1.84, trading between $4.58 and $9.93 over the past 52 weeks.
Shelton also exercised options to acquire a total of 389,720 shares of Cryoport common stock at an exercise price of $5.00 per share, for a total value of $1,948,600. InvestingPro analysis indicates the stock currently trades below its Fair Value, with analysts setting price targets ranging from $6.50 to $15.00 per share.
Following these transactions, Shelton directly owns 912,419 shares of Cryoport, Inc. For deeper insights into Cryoport’s valuation and financial health metrics, including 6 additional ProTips and comprehensive analysis, check out the detailed Pro Research Report available on InvestingPro.
In other recent news, Cryoport, Inc. has announced the completion of its sale of the specialty courier business, CRYOPDP, to DHL Group for approximately $200 million in cash. This transaction is part of a strategic partnership aimed at enhancing supply chain services for the global life sciences and healthcare sectors. The sale provides Cryoport with additional capital to focus on advancing its Life Science Services platform, particularly in the regenerative medicine market. Meanwhile, Cryoport reported its first-quarter 2025 earnings, revealing an earnings per share (EPS) of -$0.28, which surpassed the forecasted -$0.31. However, the company missed revenue expectations, generating $41 million against a forecast of $58.96 million. Despite this, Cryoport’s life sciences services revenue rose by 17%, with commercial cell and gene therapies growing by 33%. Cryoport has confirmed its full-year 2025 revenue guidance of $165-$172 million, representing a 7.5% growth at the midpoint. The strategic partnership with DHL is expected to enhance Cryoport’s global logistics capabilities, particularly in the Asia Pacific and EMEA regions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.